Keri Lantz
Keine laufenden Positionen mehr
Profil
Keri Lantz formerly worked at Achillion Pharmaceuticals, Inc., as Chief Financial & Accounting Officer in 2019.
Ms. Lantz received her undergraduate degree from Central Connecticut State University.
Ehemalige bekannte Positionen von Keri Lantz
| Unternehmen | Position | Ende |
|---|---|---|
| ACHILLION PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 11.02.2019 |
Ausbildung von Keri Lantz
| Central Connecticut State University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Achillion Pharmaceuticals, Inc.
 Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Achillion Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of oral small molecule complement system inhibitors. Its pipeline includes Danicopan and ACH-5228. The company was founded on August 17, 1998 and is headquartered in Blue Bell, PA. | Health Technology |
